Importantly, macrophages expressing high levels of CD163 and CD86 have been observed in diffuse large B cell lymphoma [58], suggesting that the NLC phenotype may be seen in other B-cell malignancies and that AHCC may be effective there as well. Here, CD163 is linked to diffuse large B-cell lymphoma.